Loading...
XSHE
002612
Market cap1.22bUSD
Dec 05, Last price  
19.47CNY
1D
0.83%
1Q
5.24%
Jan 2017
17.67%
IPO
3.30%
Name

Lancy Co Ltd

Chart & Performance

D1W1MN
XSHE:002612 chart
P/E
33.49
P/S
1.51
EPS
0.58
Div Yield, %
2.31%
Shrs. gr., 5y
1.46%
Rev. gr., 5y
13.61%
Revenues
5.69b
+10.60%
222,617,619308,998,527559,146,168836,233,0781,117,494,6811,378,831,1971,235,436,7571,144,252,8131,367,738,3302,353,265,9512,661,549,9023,007,255,1552,876,436,7293,665,214,5663,878,277,8245,145,464,4175,690,786,000
Net income
257m
+14.27%
37,645,24962,381,375123,287,041208,660,759231,290,677233,737,256121,224,94074,456,433164,015,756187,571,319210,453,08940,725,009142,036,818173,453,58334,655,348225,081,500257,203,000
CFO
567m
-32.69%
41,092,79061,813,159157,206,87564,667,8753,305,20812,912,62635,511,480150,825,033132,432,455129,370,75054,383,382596,746,640379,278,066470,584,897235,666,570841,810,542566,586,000
Dividend
May 31, 20240.45 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Lancy Co., Ltd. engages in the design, production, and sale of branded women's clothing. The company offers women's wear under the LANCYFROM25, LIMEFLARE, liaalancy, MOJOS.PHINE, JIGOTT, FABIANAFILIPPI, and m.tsubomi brand names. It is also involved in the medical and cosmetic business, which include management and operation of medical institutions under the Milan Boyu brand; laser and micro-shaping medical cosmetic services under the medical youth brand name; and operation of medical and aesthetic centers, which offer cosmetic surgery, cosmetic dermatology, cosmetic Chinese medicine, cosmetic dentistry, and micro-plastic surgery under the Gaoyisheng Medical Beauty brand. The company also provides infants and children's clothing under the Agabang, ETTOI, Putto, Designskin, and DearBaby brand names. It markets its products through stores, as well as online. The company was founded in 2000 and is based in Beijing, China.
IPO date
Aug 30, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT